Skip to main content
. 2016 Nov 16;6:244. doi: 10.3389/fonc.2016.00244

Table 1.

Front-line treatment for ovarian cancer patients.

Carboplatinum + paclitaxel (1) Platinum-based chemotherapy + anti-mitotic chemotherapy
Carboplatinum and pegylated doxorubicin (5) Platinum-based chemotherapy + intercalating DNA chemotherapy
Carboplatinum + weekly paclitaxel (6) Platinum-based chemotherapy + anti-mitotic chemotherapy
Carboplatinum and taxol + bevacizumab (7, 8) Platinum-based chemotherapy + anti-mitotic chemotherapy + angiogenesis inhibitor